Evidence map›Paper›PMID 40301965›Full record

ArticleAntimicrobial resistance and infection control2025

Duration of hospitalization increases the risk for long-term carriage of linezolid-resistant enterococci in critically ill patients.

Vera Rauschenberger, Heike Claus, Charlotte Polzin, Vera Blaschke, Stefanie Kampmeier

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Vera RauschenbergerInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, 97080, Germany. Vera.Rauschenberger@uni-wuerzburg.de.
Heike ClausInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, 97080, Germany.
Charlotte PolzinInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, 97080, Germany.
Vera BlaschkeInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, 97080, Germany.
Stefanie KampmeierInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, 97080, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEnterococci are gut commensal microorganisms, which can however cause life-threatening infections especially in patients suffering from intestinal barrier disorders. Treatment of these enterococcal infections is challenging due to a variety of intrinsic and acquired antibiotic resistances. In this context, linezolid is applied as last-resort antibiotic. Our study aimed at determining linezolid-resistant enterococci (LRE) long-term carriage (≥ 10 weeks), since this is a risk factor for the development of LRE infection.

methodsIn a one-year cohort study, all patients on hemato-oncology, intensive and intermediate care units were screened for LRE. To determine the molecular epidemiology, all detected LRE isolates were subjected to whole genome sequencing-based typing to investigate whether in-host selection or pathogen transmission was causative for LRE occurrence. Clinical and demographic data were recorded to identify risk factors for LRE clearance and persistence.

resultsLong-term LRE carriage was identified in 7 of 46 (15%) patients. Duration of hospitalization differed significantly between LRE persistence (mean: 110 days; range 28-225 days) and clearance group (mean: 53 days; range 5-213 days). LRE strains mostly exhibited a high genetic core genome diversity, indicating that transmission events played a minor role.

conclusionsOur study shows that the duration of hospitalization increases the risk for long-term carriage of LRE. In contrast to other multi drug resistant bacteria, LRE carriage was rarely caused by transmission events. Thus, future infection prevention measures should focus on antimicrobial stewardship approaches next to classical hygiene strategies.

Indexed as

Anti-Bacterial AgentsCarrier StateDrug Resistance, BacterialEnterococcusGram-Positive Bacterial InfectionsHospitalizationLinezolidAdultAgedAged, 80 and overCohort StudiesCritical IllnessFemaleHumansMaleMiddle AgedAnti-Bacterial AgentsLinezolidAntimicrobial stewardshipInfection controlLinezolid-resistant enterococciLREPersistenceRisk stratification

Identifiers

PMID40301965
PMCPMC12042563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.